imiquimod has been researched along with Genital Herpes in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.57) | 18.7374 |
1990's | 6 (21.43) | 18.2507 |
2000's | 13 (46.43) | 29.6817 |
2010's | 7 (25.00) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Barroso Dos Reis, HL; Campos, LG; da Silva Campos, LC; Jacomele Caldas, JV; Miranda, AE; Pedras Almeida, SL; Salume Costa, FL; Tosato Boldrini, NA | 1 |
Browne, R; McKendry, A; Narayana, S | 1 |
Bechtel, MA; Trout, W | 1 |
Chirachanakul, P; Jiamton, S; Leeyaphan, C; Omcharoen, V; Prasertworonun, N; Punyaratabandhu, P; Surawan, TM | 1 |
Curto-Barredo, L; Deza, G; Martin-Ezquerra, G; Pujol, RM; Villar GarcĂa, J | 1 |
Sharma, DP; Singh, J; Sinha, S; Tandon, S | 1 |
Kaul, R; Yudin, MH | 1 |
Lee, PK; Wilkins, KB | 1 |
Nisbet, M; Perkins, N; Thomas, M | 1 |
Conant, M; Schacker, TW; Smith, M; Stanczak, T; Thoming, C; Wang, Z | 1 |
Danielsen, AG; Iversen, J; Petersen, CS | 1 |
Chang, YC; Cook-Norris, R; Madkan, V; Sra, K; Tyring, S | 1 |
Brummitt, CF | 1 |
Abbo, L; Dickinson, G; Doblecki, S; Haslett, PA; Shrestha, N; Vincek, V | 1 |
Ashkar, AA; Davies, EJ; Gill, N | 1 |
Bangsgaard, N; Skov, L | 1 |
Bernstein, DI; Harrison, CJ; Miller, RL; Shahwan, A; Tepe, ER | 1 |
Bernstein, DI; Harrison, CJ; Miller, RL | 3 |
Christensen, B; Hengge, UR | 1 |
Gerster, JF; Imbertson, LM; Miller, RL; Reiter, MJ | 1 |
Drehs, MM; Gilbert, J; Weinberg, JM | 1 |
Conant, M; Schacker, T; Slade, HB; Thoming, C | 1 |
Bernstein, DI; Harrison, CJ; Miller, RL; Tomai, MA | 1 |
Bernstein, DI; Harrison, CJ; Stanberry, LR | 1 |
Bernstein, DI; Harrison, CJ; Jenski, L; Voychehovski, T | 1 |
6 review(s) available for imiquimod and Genital Herpes
Article | Year |
---|---|
Sexually transmitted diseases.
Topics: Acyclovir; Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Chancre; Condylomata Acuminata; Female; Herpes Genitalis; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Penicillins; Podophyllotoxin; Sexually Transmitted Diseases; Syphilis, Cutaneous; Uterine Cervical Neoplasms; Valacyclovir; Valine | 2015 |
Condyloma and other infections including human immunodeficiency virus.
Topics: Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Anus Neoplasms; Chancroid; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Imiquimod; Male; Penicillin G; Proctitis; Rectal Diseases; Sexually Transmitted Diseases; Syphilis; Ulcer | 2010 |
Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review.
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Fatal Outcome; Female; Herpes Genitalis; Humans; Imiquimod; Immunocompromised Host; Male; Middle Aged | 2011 |
Current and potential uses of imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Herpes Genitalis; Herpesvirus 2, Human; Humans; Imiquimod; Neoplasms; Skin Diseases; Tattooing | 2005 |
The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antiviral Agents; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Imidazoles; Imiquimod; Immunity, Innate; Ligands; Lipopolysaccharides; Mucous Membrane; Poly I-C; Toll-Like Receptors; Vagina | 2008 |
Immunomodulation as a treatment strategy for genital herpes: review of the evidence.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imidazoles; Imiquimod; Recurrence | 2002 |
1 trial(s) available for imiquimod and Genital Herpes
Article | Year |
---|---|
Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Double-Blind Method; Female; Herpes Genitalis; Humans; Imiquimod; Male; Middle Aged; Recurrence; Treatment Outcome | 2002 |
21 other study(ies) available for imiquimod and Genital Herpes
Article | Year |
---|---|
Hypertrophic genital herpes in an HIV-infected female patient: Imiquimod as an alternative treatment.
Topics: Antiviral Agents; Coinfection; Female; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Middle Aged; Ulcer; Vulva | 2020 |
Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
Topics: Acyclovir; Adult; Aminoquinolines; Antiviral Agents; Herpes Genitalis; Herpes Simplex; HIV Infections; HIV-1; HIV-2; Humans; Imiquimod; Male; Polymerase Chain Reaction; Simplexvirus; Treatment Outcome; Ulcer | 2015 |
Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
Topics: Acyclovir; Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ulcer | 2015 |
Successful treatment of hypertrophic herpes simplex genitalis in HIV-infected patient with topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Male; Middle Aged | 2015 |
Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antiviral Agents; Drug Therapy, Combination; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Immunocompromised Host; Male; Middle Aged; Valacyclovir; Valine | 2017 |
Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Resistance, Viral; Female; Foscarnet; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Hypertrophy; Imiquimod; Treatment Outcome; Vulvar Diseases | 2008 |
Chronic erosive herpes simplex virus infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir.
Topics: 2-Aminopurine; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Herpes Genitalis; Humans; Imiquimod; Male; Penile Diseases | 2002 |
Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
Topics: Acyclovir; Administration, Topical; Aged; Aminoquinolines; Antiviral Agents; Arthritis, Rheumatoid; Drug Resistance, Viral; Emollients; Female; Foscarnet; Herpes Genitalis; Humans; Imiquimod; Infusions, Intravenous; Treatment Outcome; Trifluridine; Valacyclovir; Valine | 2006 |
Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiviral Agents; Dendritic Cells; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Imiquimod; Interferon Inducers; Male | 2007 |
Chronic genital ulceration due to herpes simplex infection treated successfully with imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Chronic Disease; Female; Herpes Genitalis; Humans; Imiquimod; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell | 2008 |
Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antibody Formation; Disease Models, Animal; Female; Glycoproteins; Guinea Pigs; Herpes Genitalis; Imiquimod; Immunotherapy; Random Allocation; Viral Envelope Proteins | 1995 |
Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antibodies, Viral; Antibody Specificity; Female; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Imiquimod; Immunologic Memory; Immunosuppressive Agents; Interferon Inducers; Interleukin-2; Lymphocyte Activation; Rabbits; Simplexvirus; T-Lymphocytes; Time Factors | 1994 |
Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development.
Topics: Acute Disease; Acyclovir; Aminoquinolines; Animals; Drug Synergism; Drug Therapy, Combination; Female; Ganglia, Spinal; Guinea Pigs; Herpes Genitalis; Imiquimod; Interferon Inducers; Recurrence; Spinal Cord; Vagina; Virus Shedding | 1993 |
Recurrent urogenital herpes simplex--successful treatment with imiquimod?
Topics: Adult; Aminoquinolines; Female; Herpes Genitalis; Humans; Imiquimod; Interferon Inducers; Recurrence | 1999 |
Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod.
Topics: Aminoquinolines; Animals; Chlorocebus aethiops; Disease Models, Animal; Drug Administration Schedule; Guinea Pigs; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imiquimod; Interferon Inducers; Molecular Structure; Vero Cells | 1999 |
Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antibodies, Viral; Antibody Specificity; Antigens, Viral; Cytotoxicity, Immunologic; Enzyme-Linked Immunosorbent Assay; Female; Glycoproteins; Guinea Pigs; Herpes Genitalis; Herpes Simplex Virus Vaccines; Herpesvirus 2, Human; Imiquimod; Injections, Subcutaneous; Interferon Inducers; Interleukin-2; Killer Cells, Natural; Major Histocompatibility Complex; Viral Envelope Proteins | 2001 |
Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection.
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Herpes Genitalis; Humans; Imiquimod; Male; Treatment Failure | 2001 |
Immune booster used to fight drug-resistant herpes.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Microbial; Herpes Genitalis; HIV Infections; Humans; Imiquimod; Male | 2001 |
Imiquimod and genital herpes.
Topics: Adjuvants, Immunologic; Aminoquinolines; Herpes Genitalis; Humans; Imiquimod | 2002 |
Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antiviral Agents; Female; Guinea Pigs; Herpes Genitalis; Imiquimod; Interferon Type I; Interleukin-2; Recurrence; Simplexvirus; Ultraviolet Rays; Virus Activation | 1991 |
Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection.
Topics: Administration, Intravaginal; Aminoquinolines; Animals; Antibodies, Viral; Antibody-Dependent Cell Cytotoxicity; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Herpes Genitalis; Imiquimod; Immunity, Cellular; Interferons; Interleukin-2; Lymphocyte Activation; Neutrophils; Random Allocation; Recurrence; Simplexvirus; Vagina; Virus Replication | 1988 |